5'-Deoxy-5'-methylthioadenosine-d3
(Synonyms: 5'-S-Methylthioadenosine-d3, MTA-d3, Vitamin L2-d3) 目录号 : GC46687An internal standard for the quantification of 5’-deoxy-5’-methylthioadenosine
Cas No.:174838-38-1
Sample solution is provided at 25 µL, 10mM.
5'-Deoxy-5'-methylthioadenosine-d3 (MTA-d3) is intended for use as an internal standard for the quantification of MTA by GC- or LC-MS. MTA is an intermediate in the generation of adenine and methionine that is produced by the decarboxylation of S-adenosylmethionine.1 This nucleoside is a potent agonist of adenosine receptors (Kis = 0.15, 1.13, 13.9, and 0.68 μM for A1, A2A, A2B, and A3, respectively).2 At higher concentrations, MTA inhibits several enzymes, including protein carboxylmethyltransferase (Ki = 41 μM), S-adenosylhomocysteine hydrolase, SET methyltransferases, and spermidine and spermine synthases.3,1,4,5
1.Huang, S.Histone methyltransferases, diet nutrients and tumour suppressorsNat. Rev. Cancer2(6)469-476(2002) 2.Kehraus, S., Gorzalka, S., Hallmen, C., et al.Novel amino acid derived natural products from the ascidian Atriolum robustum: Identification and pharmacological characterization of a unique adenosine derivativeJ. Med. Chem.47(9)2243-2255(2004) 3.Oliva, A., Galletti, P., Zappia, V., et al.Studies on substrate specificity of S-adenosylmethionine: Protein-carboxyl methyltransferase from calf brainEur. J. Biochem.104(2)595-602(1980) 4.Cole, P.A.Chemical probes for histone-modifying enzymesNat. Chem. Biol.4(10)590-597(2008) 5.Lee, S.H., and Cho, Y.D.Induction of apoptosis in leukemia U937 cells by 5'-deoxy-5'-methylthioadenosine, a potent inhibitor of protein carboxylmethyltransferaseExp. Cell Res.240(2)282-292(1998)
Cas No. | 174838-38-1 | SDF | |
别名 | 5'-S-Methylthioadenosine-d3, MTA-d3, Vitamin L2-d3 | ||
Canonical SMILES | O[C@H]1[C@H](N2C=NC3=C2N=CN=C3N)O[C@H](CSC([2H])([2H])[2H])[C@H]1O | ||
分子式 | C11H12D3N5O3S | 分子量 | 300.3 |
溶解度 | DMF: soluble,DMSO: slightly soluble,Methanol: slightly soluble | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.33 mL | 16.65 mL | 33.3 mL |
5 mM | 0.666 mL | 3.33 mL | 6.66 mL |
10 mM | 0.333 mL | 1.665 mL | 3.33 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet